Centennial Bank’s Bristol-Myers Squibb BMY Stock Holding History

Centennial Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$546K	Sell	9,469 -1,000	-10%	-$57.4K	0.18%	95
2026 Q1	$635K	Hold	10,469	–	–	0.23%	89
2025 Q4	$565K	Sell	10,469 -100	-0.9%	-$4.81K	0.22%	87
2025 Q3	$477K	Hold	10,569	–	–	0.19%	93
2025 Q2	$489K	Sell	10,569 -215	-2%	-$10.6K	0.21%	86
2025 Q1	$658K	Buy	10,784 +300	+3%	+$17.5K	0.31%	73
2024 Q4	$593K	Sell	10,484 -20	-0.2%	-$1.12K	0.28%	77
2024 Q3	$543K	Sell	10,504 -24	-0.2%	-$1.13K	0.25%	81
2024 Q2	$437K	Sell	10,528 -2	-0%	-$89	0.21%	87
2024 Q1	$571K	Sell	10,530 -2,000	-16%	-$102K	0.29%	76
2023 Q4	$643K	Buy	12,530 +22	+0.2%	+$1.16K	0.38%	62
2023 Q3	$726K	Hold	12,508	–	–	0.5%	57
2023 Q2	$800K	Hold	12,508	–	–	0.54%	53
2023 Q1	$867K	Sell	12,508 -750	-6%	-$52.9K	0.57%	52
2022 Q4	$954K	Buy	+13,258	New	+$1,000K	0.55%	55

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Centennial Bank's BMY Position: Q2 2026 in Review

Centennial Bank reduced its Bristol-Myers Squibb (BMY) stake by 9.6% in Q2 2026, selling an estimated $57.4K and leaving 9,469 shares worth $546K. The position accounts for 0.18% of the portfolio, ranked #95.

Centennial Bank first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $954K in Q4 2022. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Centennial Bank held 9,469 shares of Bristol-Myers Squibb worth $546K as of Q2 2026.
Centennial Bank sold 1,000 Bristol-Myers Squibb shares in Q2 2026, an estimated $57.4K.
Bristol-Myers Squibb made up 0.18% of Centennial Bank's portfolio in Q2 2026, its #95 holding.
Centennial Bank first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
Centennial Bank's Bristol-Myers Squibb position peaked at $954K in Q4 2022.
2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Centennial Bank's 13F filing for Q2 2026, filed 10 Aug 2026.